OGN

Organon & Co. (OGN)

About Organon & Co. (OGN)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Details

Daily high

$16.23

Daily low

$15.74

Price at open

$16.13

52 Week High

$23.10

52 Week Low

$13.87

Market cap

4.1B

Dividend yield

7.12%

Volume

2.9M

Avg. volume

2.8M

P/E ratio

3.12

Organon & Co. News